Good morning and welcome to Wiley's Q3 Fiscal 2024 Earnings Call. As a reminder, this conference is being recorded. At this time, I'd like to introduce Wiley's, Vice President of Investor Relations, Brian Campbell. Please go ahead..

Thank you and welcome everyone. With me today are Matt Kissner, Wiley's Interim President and CEO; Christina Van Tassell, Executive Vice President and CFO; and Jay Flynn, Executive Vice President and General Manager of Research and Learning.

Note that our comments and responses to your questions reflect management's views as of today and will include forward-looking statements. Actual results may differ materially from those statements. The company does not undertake any obligation to update them to reflect subsequent events or circumstances.

Also Wiley provide non-GAAP measures as a supplement to evaluate underlying operating profitability and performance trends. These measures do not have standardized meanings prescribed by U.S. GAAP and therefore, may not be comparable to similar measures used by other companies nor should they be viewed as alternatives to measures under GAAP.

Unless otherwise noted, we will refer to non-GAAP metrics on the call and variances are on a year-over-year basis and will exclude held-for-sale assets and the impact of currency. Additional information is included in our filings with the SEC.

A copy of this presentation and transcript will be available on our Investor Relations web page at investors.wiley.com. I'll now turn the call over to Matt Kissner..

Thank you, Brian and hello everyone. I am fighting a bit of a cold this morning, so if I sound muted, you'll understand why. Let me start by saying we're seeing marked improvement as we enter the home stretch of this transition year. I'll talk about our overall progress to-date, review our third quarter performance, and recap our recent investor event.

I'll also provide some additional color on how we view the evolving AI opportunity. Christina will walk through our VCP progress, segment performance, and full year outlook. We'll then open it up for questions and Jay will be joining us as well. 2024 marks Wiley's 217th year.

As one of America's most enduring companies, Wiley is enabling the creation and curation of new knowledge and its application in critical areas of the knowledge economy in science, technology, and engineering and business, economics, and finance. We are as relevant as ever. Let's turn to our progress to-date.

We have moved decisively to improve the organization, divest non-core assets, and right-size Wiley for future success. We've now announced the sale of two of our three divestitures and closed on one of them.

Our goal of course is to free ourselves of these non-core assets to focus on our profitable and cash generative core where we have clear competitive advantage, operating leverage, and growth opportunities. We've made very good progress on our $130 million cost savings program with 60% of it action to-date.

We've moved more aggressively on it than originally planned, resulting in higher in-year savings, which Christina will talk to. Learning continues to outperform expectations and positive signs are emerging in Research with Publishing returning to growth this quarter and leading indicators favorable.

Overall, we now expect full year revenue to be in the mid- to high range of guidance. Finally, given revenue expectations and accelerated in-year savings, we are raising our full year earnings outlook. In summary, while much work remains, we're pleased with our progress and continued momentum. Let me now turn to our performance for the quarter.

GAAP revenue was down 6% impacted by the sale of our University Services business, and a decline in our held-for-sale assets given market conditions. GAAP EPS declined by $0.79 a share for a GAAP loss of $2.08, primarily due to material non-cash impairments and loss on sale related to our divestitures.

Let me acknowledge the obvious that it's been a long stretch of write-downs and impairments related to these divestitures. We don't anticipate any further material write-downs of these assets, and we certainly look forward to putting it all behind us. On to our adjusted results.

Note, we'll be excluding our held-for-sale or sold assets in our commentary performance and outlook, unless otherwise noted. Q3 adjusted revenue growth of 1%, was largely in line with our expectations.

In Research, we saw a return to year-on-year growth for Publishing, driven by double-digit gold open access growth, and positive contribution from our multiyear institutional models. This was partially offset by the remaining year-over-year drag of Hindawi. Excluding Hindawi Research Publishing revenue for the quarter was up 2%.

So we feel good about the improvement in our core. As a reminder, we are integrating Hindawi's quality journal portfolio into our own and using its world-class infrastructure for our Open Access program. So we'll be talking about the performance of the overall program going forward.

In Learning, we continue to see out performance in our academic learning with growth attributed to digital courseware, digital content and licensing. Our zyBooks STEM courseware and inclusive access sales model continue to show strong gains. Inclusive Access, adds the cost of digital course content into students' tuition and fees.

As a reminder, US undergraduate enrollment in the full semester grew for the first time since the pandemic. So Higher Ed market conditions have become more favorable this year.

Adjusted EBITDA for the quarter rose 1% to $92 million, with revenue performance and restructuring savings offsetting a materially lower incentive compensation accrual in the prior year. Adjusted EPS was down 27% as expected, primarily due to higher tax expense related to geographic mix and lower adjusted operating income.

For those that may have missed it, we held a virtual investor update on January 25 to share our near- to medium-term plans and financial targets. The feedback so far has been positive, and we're now focused on executing and delivering on our commitments. Let me briefly summarize our key takeaways. Today's Wiley is a very different company than before.

We are focused on our strongest and most profitable businesses in Research and Learning, where we have our strongest opportunities moats and margins.

We're taking specific actions to drive market share, attract new authors and article submissions and strengthen our brands and partnerships, we will do this while maintaining the quality and impact that Wiley is famous for. AI and machine learning are attractive opportunities for us, which I'll talk more about on the next slide.

We see a very real opportunity to embed our content into large language models and training engines. Internally, we will be deploying the technology to improve productivity and publishing speed, quality and volume. And finally, we are heavily focused on improving our operating and publishing efficiency.

We are moving from multiple disparate publishing platforms to one flagship submission and peer review experience for our research authors. This will make it easier for us to stand up new content offerings and enhance the ones we already have.

Moreover, we expect this next-generation platform to lead to a material reduction in article turnaround times and cost per article. And of course, we're driving cost savings and efficiency gains across the organization. Let's turn to the AI opportunity and how we see it shaping up.

We are confident that the advancement of these technologies will be a contributor to productivity and growth in the years to come. Today we think of the opportunity in four areas. The first is in licensing our content for large language models and similar applications.

Wiley's strength is in its high-quality structured content in science, learning and innovation, areas that are critical to economic and technological progress. As we discussed on our investor update, our content is foundational for training and fine-tuning these models.

I'm pleased to report that after the quarter closed, we executed a $23 million content rights project with a large tech company. The one-time transaction to be recorded in Q4 includes access to previously published academic and professional book content for specific use in training LLM models.

We are working to uncover similar content opportunities with other AI players and remain convinced that the future development of LLMs is best served by the high-quality structured content that Wiley delivers. The second area we focused on is product and publishing innovation.

Today we are actively building and deploying AI editing tools to improve speed and quality of our journal content and reduce unit costs through process automation in the value chain. To accomplish this, we have built an award-winning AI R&D team and are actively working with an international AI advisory team that includes professors, Ph.D.

researchers and AI thought leaders. These efforts are paying off. For example, we recently launched an internal pilot of our AI-powered article matching engine to help authors get published faster and in the right journals. We have also learned valuable lessons about promoting research integrity from our Hindawi experience.

Our teams are leveraging our data about bad actors and retracted papers. Such data is proving indispensable for training robust, accurate and efficient AI fraud detection models. Most notably, we're focused on paper mill detection, where we're aiming to identify even the most subtle indicators of fraudulent activity.

As stated before, this is an industry-wide issue and a top priority for us and our solutions customers. So we're taking the lead by both deploying these tools across our journal portfolio and bringing to market where they can be incorporated into our clients' existing systems. Thirdly, we're using AI to drive business model innovation.

As Jay mentioned, during our Investor Day, Wiley publishes a number of datasets that are directly loaded on to lab instruments to help determine the chemical structure of a sample. This proprietary library of mass spectrometry data has critical applications ranging from airport security and food analysis to drug discovery and biofuel generation.

Our most recent product release uses AI to analyze not only known chemical compounds, but unknown compounds to predict among other things their safety utility and toxicity. This is just one example of many, where we're using AI to innovate, transform content application and distribution models and bring Wiley's products closer to the customer.

Finally, we're deploying AI to improve colleague productivity, in areas like sales and marketing, editorial, content management and customer service. This will lead to further efficiency, faster time to market and improved customer response. In summary, we're excited and confident in our position in this evolving new digital economy.

With that, I'll turn it over to Christina to discuss our progress, performance and outlook..

Corporate savings and eliminating costs given our more focused portfolio; optimization with savings coming from our streamlined org structure, consolidated functions, labor arbitrage and reduced real estate footprint; and technology savings, as we simplify our platforms to retire legacy systems and reduce hosting costs.

As discussed in January, we expect half of the multiyear savings to flow through to margin and half to be reinvested in profitable growth and optimization initiatives.

These include -- our research journal brands to meet global demand, expanding our editorial and marketing capabilities to drive output and attract authors, expanding solutions offerings to win new partners and drive upsell, and modernizing our Research Publishing platform. Let's turn to our research performance.

Research Publishing returned to year-over-year growth this quarter and we continue to see good momentum in our key leading indicators.

Of note excluding Hindawi, Research Publishing revenue was up 2% on the strength of gold open access and our institutional models, which include both read-only subscriptions and read and published transformational agreements.

Submissions were up 13% year-to-date, and output continues to improve as we work through the long lead time to convert a submitted article into a published one. These submission numbers point to good underlying progress in our author marketing efforts editorial commissioning and refer transfer activities.

As we mentioned in our Investor Update, these article submissions power all of our journal business models including subscriptions, transformational agreements and gold open access.

Conversion to revenue, therefore, depends on these business models, as well as other factors such as geography, acceptance rates in individual journals, and of course, overall manuscript quality. As Matt noted, we're folding Hindawi into our existing journal portfolio.

Integrating Hindawi gives us an additional 270 OA journals of which 75% or 200 have impact factors, marking them as high quality. Also, we recently announced institutional open access agreements with several consortia around the world, including the University of California system in the U.S. and JISC in the U.K.

These types of multiyear read and publish agreements as well as our traditional subscriptions are foundational to our large global customer base of leading universities, government institutions, and corporate customers. This quarter we saw over 30% growth in Gold OA excluding Hindawi.

Gold OA our author paid model makes up about 11% of our Research Publishing revenue. It's the fastest-growing area in our Research segment. Turning to Research Solutions. Revenue declined 1% this quarter due to continued market softness in both advertising and our projects business in the health care sector.

This decline in corporate revenue offset continued growth from our Publishing Solutions business, notably consulting and managed services for society partners. Adjusted EBITDA in research this quarter declined 2% mainly driven by higher editorial and marketing costs and the impact of Hindawi.

Our Q3 adjusted EBITDA margin was 30.9% down from 31.7% in the prior period. So overall in research, we are seeing recovery as expected both in our year-over-year revenue performance and in our leading indicators. Let's turn now to Learning.

Our academic line continues to perform well up 5% in the quarter driven by double-digit growing digital courseware, digital content and licensing. As Matt noted, US fall enrollment grew for the first time since endemic. Professional declined 3% in the quarter driven by softness in business and technology publishing categories.

For the year, we continue to see outperformance in learning. On top of that as Matt discussed, we're beginning to monetize our learning content for AI models and training engines, showcasing the value of our authoritative content in advancing the evolution of AI.

Adjusted EBITDA from learning remains a positive story, up 15% this quarter and year-to-date with revenue growth and restructuring savings as the primary drivers. Our Q3 adjusted EBITDA margin was 35%, up from 31% in the prior period. Now let me touch on our corporate expenses.

We saw a $4 million increase over prior year due to unfavorable comps, notably the materially lower incentive accrual in the prior year period. This offset restructuring savings. As noted, we expect corporate expenses to be up moderately this transition year due to the continued carrying costs related to our held-for-sale assets.

As we transition out of these assets and further optimize our cost structure, we'll see our cost ratios improve next year and beyond. Now on to our cash flow and balance sheet. Free cash flow for the nine months was a use of $45 million compared to a use of $22 million in the prior year.

The negative variance was driven by the timing of closing journal subscription renewal and the higher restructuring payments related to our value creation plan. CapEx of $70 million is tracking $5 million below prior year.

We expect to close the remaining journal subscription renewals in Q4 and remain on track to deliver approximately $100 million of free cash flow for the full year. Year-to-date, we allocated $87 million towards dividends and share repurchases with share repurchases being $5 million higher than prior year.

$29 million was used to acquire 872,000 shares at an average cost per share of $33.24. This compares to 540,000 shares repurchased in the prior year period. Our current dividend yields remained above 4%. Net debt-to-EBITDA ratio was 1.9 at the end of January, compared to 2.1 in the prior year period.

Through the fiscal 2025, 20'26 plan period, we're going to continue to manage down debt and interest expense while balancing other capital priorities including investing in scale in research, repurchasing shares opportunistically and supporting a healthy dividend.

Note we have reduced our net debt by over $21 million compared to the prior year period. Our upfront cash proceeds from the divestitures are not material, although we fully expect to collect the cash from the notes over time with interest. Let's turn to our full year outlook with one quarter remaining.

We see adjusted revenue trending upward in the mid to high end of our range. This is driven by learning outperformance throughout the year, augmented by the learning content rights deal expected in Q4. We are raising our adjusted EBITDA guidance to be in a range of $335 million to $355 million, up from the original $305 million to $330 million.

Our improved outlook reflects the $15 million of additional in-year cost savings from our value creation plan and a full year outperformance in learning including the Q4 content deal. We're now projecting a full year EBITDA margin of 21% to 22% and an increase from the previously projected 19% to 20%.

To refresh, we continue to expect to more than recover our fiscal 2023 adjusted EBITDA margin of 23.3% as we exit fiscal 2024. We're also raising our adjusted EPS guidance to a range of $2.45 to $2.65, up from $2.05 to $2.40, due to a higher-than-expected adjusted operating income and accrued interest income from our University Services divestiture.

We expect free cash flow to be approximately $100 million in this transition year. This summer is unusually low for Wiley, given the combination of lower cash earnings, higher restructuring payments and higher interest payments. As laid out in January, we're targeting significant free cash flow improvement in fiscal 2025 and again in fiscal 2026.

In summary, I'm very pleased with how we as an organization are executing on multiple levels while tackling our cost structure. As we make our way into fiscal 2025 and through 2026, we're confident in our ability to deliver on our revenue, our margin expansion and our cash flow trajectory. And with that I'll pass it back to Matt..

Thank you, Christina. Let me recap some personal observations I've had so far. Wiley is a terrific company. Yes, we're coming out of a difficult period, but refocusing on our core makes us a stronger, more profitable company and presents a very rich set of opportunities to build on.

Our businesses are fundamentally strong, built on long-term relationships with research institutions, academic societies and R&D-driven corporations.

We have a unique right to win in Research, driven by a wide moat, built around the enduring draw of our journal brands and platforms and a strong position in learning built on our content, library and franchises. Our markets are healthy. Global R&D spend is ever increasing, as is the demand for new knowledge in the verticals we serve.

Very importantly, the name Wiley means something special to our customers. It's why we're trusted by the most prestigious universities and societies in the world, Nobel Prize-winning authors and major pharmaceutical companies. We have an absolutely terrific team.

Our global colleagues are reinvigorated by our move to a simpler, more confident Wiley and are empowered now to identify incremental growth opportunities and better ways of working. I recently returned from India, where we have a publishing operation and Sri Lanka, where we have a world-class tech development and IT center.

As with my November visit to our European offices, I find our culture to be reenergized by our increased focus and momentum. And finally, what we do is good for the world. This is not a slogan. We are actively contributing to major scientific and economic progress as well as the everyday progress of the individual.

This mission energizes Wiley colleagues across the globe. Let me quickly summarize the key takeaways. We're pleased with the improvement and underlying momentum we're seeing in Research and our continued outperformance in Learning. We remain relentlessly focused on execution. We're being fanatical about prioritization and blocking and tackling.

I'm seeing early signs of progress already. There's just an increasing sense of confidence and a thoughtful sense of urgency in the place. That said, we're still in a transition year. Although, we've made good progress overall, and see our core drivers rebounding and earnings guidance raised, we still have important work in front of us.

We look forward to putting this year, and all its complexities behind us. I'll quickly conclude with our financial targets, which we laid out in January. On revenue, we anticipate low single-digit growth in fiscal 2025 as our core drivers in Publishing continue to rebound, increasing to low to mid-single-digit revenue growth in fiscal 2026.

Our margins are expected to expand to 23% to 24% in fiscal 2025, and then to 24% to 25% in fiscal 2026. And with our ongoing efficiency gains, and disciplined capital allocation, we're going to continue to focus on margin expansion beyond fiscal 2026.

Free cash flow is expected to step up to approximately $125 million in fiscal 2025, as we balance improved cash earnings with necessary investment in research and in infrastructure modernization. We're then targeting approximately $200 million in fiscal 2026 as CapEx returns to more normalized levels and restructuring payments taper off.

Beyond fiscal 2026, we're going to continue to focus on increasing our free cash flow conversion from the 45% or so we anticipate in fiscal 2026. Before I open it up for questions, I want to thank all of you for joining us today. As always, I want to thank our Wiley colleagues for their continuous drive and thoughtful collaboration.

Nothing unites us more than being on a winning team. I'll now open the floor to any comments and questions..

[Operator Instructions] And your question comes from the line of Dan Moore with CJS Securities. Your line is open..

Hi. Good morning. It's Pete Lukas for Dan today. First congratulations on the progress made in the quarter. And just wanted to start with a question regarding Hindawi.

What level of recovery or profitability is embedded in your fiscal 2025 goal of the 23% to 24% EBITDA margins?.

Hi, Pete, it's Matt. I'm going to ask Christina to respond..

Sure. Hi, Pete nice to speak to you, again. So we -- as we've said before, our Hindawi recovery is a bit slower than expected, but we are expecting some future improvement in 2026 and beyond. And I don't know, if you want to go into some detail Jay on the --.

Yeah, I'm happy to. It's Jay Flynn. So we're clearly anticipating progress in 2025, 2026 on Hindawi. As we've said before, we expect growth rates there on the top line to mirror what we see in the rest of our Gold Open Access portfolio. And the margins there will reflect generally speaking the margins in our journal operations.

So we haven't broken that out specifically. As a reminder, this is not a -- it's less than 5% of total Research revenue. So, we're not breaking that out at that level..

Perfect. And then you touched on it at the end, but one part of your recent Investor Day that maybe didn't get enough attention is a significant improvement in free cash flow you're targeting with expected to jump from $100 million to $200 million from 2024 to 2026.

Can you just give us a little bit more detail and kind of maybe walk us through the key assumptions around the goals and what are the biggest risks in your view to achieving those goals?.

Sure. So, yes, we are seeing us returning to approximately $200 million by fiscal year 2026 in free cash flow. The primary drivers of that are obviously our improvement in our revenue recovery as well as the impact of our cost-out programs and that taking full effect.

We've had some lower-than-expected cash flow needs for things like restructuring payments and interest has been higher than expected. And so those things will level out.

The other thing that's going to impact our cash flow over the next two years is we're going to see next year in fiscal 2025, a spike in CapEx from about $100 million to $130 million and that's for some of the programs we're talking about in terms of revenue growth items as well as optimization items as I mentioned in my prepared remarks.

The other thing to note there is that that will come back down in fiscal year 2026 as we continue to normal out. You can see a sort of a cash flow trajectory of $200 million that will be sort of our steady-state run rate going forward..

Very helpful. Thanks. And then you talked about leverage. I think you said down now to about 1.9 times. And I think it's predicted to fall to about 1.5 times by 2026.

Given your current valuation and your expectations on the free cash flow as discussed, what are your -- how do you think about stock buybacks rather than continuing to delever the balance sheet at those levels?.

Look we're always looking at our stock buyback program. It's something that we review with the Board annually and we're in a transition year right now. So, we're looking at all of our capital allocation in total as a portfolio. And so yes, we look at it every year. We continue to look at it.

As I mentioned in our prepared remarks we're $5 million ahead in share repurchases this year versus prior year and we'll continue to keep that in mind going forward..

And then just the last one for me. I just want to make sure I caught it right from the prepared remarks. In terms of the cost savings, the $130 million 60% achieved to-date but then you see the bulk of that $50 million in 2025.

So, not expecting a lot in 2026 and beyond is that correct?.

Beyond the $130 million or within the $130 million? So, the $130 million is -- sorry go ahead just to clarify that..

Yes. No, it was just the cost savings overall was using your $130 million number that you mentioned..

Right. So, $130 million is our run rate savings by the end of 2026. And most of that will be -- most of the remaining $50 million. So, that's the 40% left will be actioned in fiscal year 2025 and that's -- and it's basically in three buckets the corporate savings, the business optimization, and the technology savings.

Did that answer your question?.

Yes. Very helpful. Thank you. And that’s it for me, so I'll jump back in the queue..

There are no further questions at this time. I will now turn the call back to Mr. Kissner for closing remarks..

Thank you, everyone. We appreciate the interest. Obviously, we're feeling good about the last quarter of the year. We've got a little bit of wind at our back and renewed and confidence and we're looking forward to our next update with you in June where we talk about our full year results. Thanks very much..

This concludes today's call. You may now disconnect..